(Q33799039)

English

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

HIV transmission

0 references

1 reference

based on heuristic

inferred from title

viral transmission

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Tabor E

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11-12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1160-1168

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Incomplete inactivation of hepatitis B virus after heat treatment at 60 C for 10 hours

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Transmission of hepatitis B by immune serum globulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis B Virus Infection in Chimpanzees: Titration of Subtypes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Testing of immunoglobulin products for hepatitis C virus by polymerase chain reaction: importance of an internal control.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Non-A, non-B hepatitis from intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis C transmission associated with intravenous immunoglobulins.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis C virus RNA in factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Incidence of hepatitis C virus RNA in anti-HCV-negative plasma pools and blood products

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Viral dynamics in primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Effect of heat on the agent of homologous serum hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis???associated antigen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis C infection from anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Anti-HCV screening and plasma fractionation: the case against

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Hepatitis B immune globulin and immune serum globulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Safety of immune serum globulin with respect of homologous serum hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Safety of blood products derived from plasma pools: the positive impact of anti-HCV screening on the quality of such products

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Elimination of infectious retroviruses during preparation of immunoglobulins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39111160.X

21 January 2018

Identifiers

10.1046/J.1537-2995.1999.39111160.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33799039&oldid=2060266991"